Advertisement

Biobanks and Ethics Committees

  • Laura Palazzani
Chapter
  • 151 Downloads

Abstract

Experimentation is almost always strictly connected to the use of biological samples and to biobanks. Experimentation of drug on human beings generally imply the research on biological samples and their genetic materials. Biobanks are units that collect biological samples by individuals or groups, together with their personal information. The chapter analysis the different theories, in a pluralistic setting, focusing on the concept of ‘donation’ of samples (form individualism to communitarianism), underlining the implication on informed consent. A specific role of Ethics Committees or Institutional Review Boards is highlighted.

References

  1. Cambon-Thomson, A. (2004). The social and ethical issues of post-genomic biobanks. Nature Reviews Genetics, 5, 866–873.CrossRefGoogle Scholar
  2. Council of Europe (CoE). (2016). Recommendation CM/Rec(2016)6 of the committee of ministers to member states on research on biological materials of human origin.Google Scholar
  3. Dabrock, P., Taupitz, J., & Ried, R. (2010). Trust in biobanking: Dealing with ethical, legal and social issues in an emerging field of biotechnology. Dordrecht: Springer.Google Scholar
  4. Dierickx, K., & Borry, P. (2009). New challenges for biobanks: Ethics, law and governance. Cambridge: Intersentia Publishers.Google Scholar
  5. Elger, B., Mauron, A., Capron, A. M., & Andorno, R. B. (2008). Ethical issues in governing biobanks. Global perspectives. London: Ashgate Publishing.Google Scholar
  6. European Commission. (2012). Biobanks for Europe. A Challenge for Governance. Report of the Expert Group on Dealing with Ethical and Regulatory Challenges of International Biobank Research.Google Scholar
  7. French National Consultative Ethics Committee for Health and Life Sciences. (2003). Ethical issues raised by collections of biological material and associated information data: “Biobanks”, “Biolibraries”.Google Scholar
  8. Friesen, P., Kearns, L., Redman, B., & Caplan, A. L. (2017). Rethinking the Belmont Report. The American Journal of Bioethics, 17(7), 15–21.CrossRefGoogle Scholar
  9. Hansonn, M. G. (Ed.). (2001). The use of human biobanks. Ethical, social, economical and legal aspects. Uppsala: Uppsala University.Google Scholar
  10. Italian Committee for Bioethics. (1992). Ethics committees.Google Scholar
  11. Italian Committee for Bioethics. (1997). Ethics committees in Italy: Recent issues.Google Scholar
  12. Italian Committee for Bioethics. (2006). Biobanks and research on human biological material.Google Scholar
  13. Italian Committee for Bioethics. (2009). Collection of biological samples for research purposes: Informed consent.Google Scholar
  14. Italian Committee for Bioethics. (2014). Paediatric biobanks.Google Scholar
  15. Italian Committee for Bioethics. (2015). Motion on the implementation of regulation (E.U.) no. 536/2014 of the European Parliament and the Council of 16 April 2014, in the subject of clinical trials on medicinal products for human use, repealing directive 2001/20/EC.Google Scholar
  16. Italian Committee for Bioethics. (2017). Clinical ethics committees.Google Scholar
  17. Knoppers, B. M. (2006). Biobanks: New challenges for bioethics and biolaw. Iustitia, 1, 47–53.Google Scholar

Copyright information

© Springer Nature Switzerland AG and G. Giappichelli Editore 2019

Authors and Affiliations

  • Laura Palazzani
    • 1
  1. 1.Department of Law, Economics, Politics and Modern LanguagesLUMSA UniversityRomeItaly

Personalised recommendations